Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 188,744 shares at $266.66 ($51.0M) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $51.0M VRTX by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $265.57 | 4,220 | $1.1M | 2.2% |
| 2 | $265.57 | 4,220 | $1.1M | 2.2% |
| 3 | $266.66 | 4,921 | $1.3M | 2.6% |
| 4 | $266.66 | 4,921 | $1.3M | 2.6% |
| 5 | $267.62 | 10,878 | $2.9M | 5.7% |
| 6 | $267.62 | 10,878 |
| $2.9M |
| 5.7% |
| 7 | $268.86 | 22,613 | $6.1M | 11.9% |
| 8 | $268.86 | 22,613 | $6.1M | 11.9% |
| 9 | $269.56 | 15,681 | $4.2M | 8.3% |
| 10 | $269.56 | 15,681 | $4.2M | 8.3% |
| 11 | $270.86 | 6,003 | $1.6M | 3.2% |
| 12 | $270.86 | 6,003 | $1.6M | 3.2% |
| 13 | $272.12 | 11,832 | $3.2M | 6.3% |
| 14 | $272.12 | 11,832 | $3.2M | 6.3% |
| 15 | $272.97 | 12,849 | $3.5M | 6.9% |
| 16 | $272.97 | 12,849 | $3.5M | 6.9% |
| 17 | $273.70 | 5,375 | $1.5M | 2.9% |
| 18 | $273.70 | 5,375 | $1.5M | 2.9% |
| Total | $269.94 avg | 188,744 | $51.0M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |